BRIDGE HOUSE MEDICAL PRACTICE — All Prescriptions & Medications
Practice Code: Y03135 | LONDON, N4 1TL
Over the last 12 months, BRIDGE HOUSE MEDICAL PRACTICE prescribed 80,222 items across 462 different medications at a total cost of £716,855 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Valsartan | 10 | 672 | £160 | -83.0% ▼ |
| Tiotropium bromide/olodaterol | 10 | 15 | £463 | -83.7% ▼ |
| Desloratadine | 10 | 696 | £60 | -65.3% ▼ |
| Ivermectin | 10 | 62 | £766 | +2.5% ▲ |
| Combined ethinylestradiol 35mcg | 10 | 945 | £56 | -19.7% ▼ |
| Ergocalciferol | 10 | 584 | £248 | -40.3% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 10 | 120.0K | £3.0K | -6.3% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 10 | 1,000 | £47 | -33.4% ▼ |
| Tizanidine hydrochloride | 10 | 1,428 | £62 | -62.2% ▼ |
| Urea hydrogen peroxide | 10 | 80 | £33 | +99.6% ▲ |
| 10 | 122 | £117 | -69.1% ▼ | |
| 10 | 140 | £62 | -73.0% ▼ | |
| Lorazepam | 11 | 331 | £32 | -92.3% ▼ |
| Rivastigmine | 11 | 330 | £760 | -84.0% ▼ |
| Dienogest | 11 | 308 | £214 | +51.9% ▲ |
| Cabergoline | 11 | 88 | £157 | -29.1% ▼ |
| Metronidazole | 11 | 480 | £49 | +66.3% ▲ |
| Powder preterm infant formula (0913111) | 11 | 28.0K | £430 | -30.9% ▼ |
| Ivermectin | 11 | 615 | £356 | -48.3% ▼ |
| Metronidazole | 11 | 440 | £183 | -70.7% ▼ |
| 11 | 750 | £100 | -5.8% ▼ | |
| 11 | 420 | £1.4K | -10.3% ▼ | |
| 11 | 788 | £90 | -86.3% ▼ | |
| 11 | 1,100 | £257 | -28.6% ▼ | |
| Misoprostol | 12 | 1,344 | £215 | +24.5% ▲ |
| Glycerol | 12 | 149 | £23 | -65.8% ▼ |
| Fenofibrate | 12 | 336 | £28 | -87.6% ▼ |
| Umeclidinium bromide | 12 | 13 | £340 | -80.5% ▼ |
| Vortioxetine | 12 | 420 | £395 | -82.7% ▼ |
| Azithromycin | 12 | 445 | £114 | -90.5% ▼ |
| Anastrozole | 12 | 588 | £23 | -86.8% ▼ |
| Ready to serve infant formula, high energy (0913104) | 12 | 79.6K | £1.3K | +8.6% ▲ |
| Apraclonidine | 12 | 79 | £209 | -4.7% ▼ |
| Malathion | 12 | 3,600 | £326 | +87.9% ▲ |
| 12 | 105 | £49 | -58.6% ▼ | |
| 12 | 120 | £31 | -7.1% ▼ | |
| 12 | 3,000 | £427 | -69.2% ▼ | |
| 12 | 7,800 | £1.6K | -56.1% ▼ | |
| 12 | 600 | £179 | +55.5% ▲ | |
| 12 | 600 | £3.1K | -46.2% ▼ | |
| 12 | 470 | £1.8K | -73.5% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 13 | 1,456 | £173 | -62.6% ▼ |
| Guanfacine | 13 | 364 | £723 | -49.4% ▼ |
| Ondansetron hydrochloride | 13 | 480 | £123 | -73.2% ▼ |
| Opicapone | 13 | 390 | £767 | -32.1% ▼ |
| Pramipexole | 13 | 364 | £19 | -86.8% ▼ |
| Levodopa/carbidopa/entacapone | 13 | 1,560 | £1.0K | -53.5% ▼ |
| Rotigotine | 13 | 364 | £1.9K | -51.8% ▼ |
| Acamprosate calcium | 13 | 2,184 | £234 | -62.7% ▼ |
| Repaglinide | 13 | 2,160 | £172 | -46.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.